← All terms
CATEGORY: SAFETY SURVEILLANCE
Post-Market Surveillance (PMS)
The systematic collection, analysis, and interpretation of data about medical devices after market placement. Under EU MDR, manufacturers must implement a proactive PMS system proportionate to device risk class.
Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy
WHEN IT APPLIES
Post-market surveillance systematically collects and analyzes real-world device experience after launch. Under EU MDR it must be proactive and proportionate to risk class.
PROCESS / STEPS
- Write a PMS plan linked to residual risks and clinical questions.
- Collect complaints, literature, registries, and regulatory signals.
- Analyze trends; feed CAPA, risk file, and clinical evaluation.
- Produce PSUR/PMS reports on the required cadence.
EXAMPLES
- Class III implants typically need denser PMCF/PMS than Class I devices.
RELATED GUIDES & TOOLS
SOURCES
Track regulatory signals related to Post-Market Surveillance (PMS) across 27 authorities in real time.
START FREE →